1500 San Pablo Street, Los Angeles, CA, 90033 · (323) 442-8656
Beds
307
FY 2025
Star rating
5 of 5
Patient survey: 4 of 5
Net patient revenue
$1.48B
FY 2025
Net income
-$121.2M
Patient care margin -20.4%
Discharges
12,230
Occupancy 75.9%
Clinicians
1,110
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1.48B | $1.78B | -20.4% | -$121.2M | 12,230 | $5.4M | 30.6% | 4.2% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate after heart bypass surgery | 1.9% | US median 2.3% |
| Death rate for heart failure patients | 7.7% | US median 11% |
| Hospital-wide death rate within 30 days | 3% | US median 3.9% |
| Death rate for pneumonia patients | 13.3% | US median 15.2% |
| Death rate for stroke patients | 10.9% | US median 11.6% |
| Readmission rate after heart bypass surgery | 11.5% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
| Diagnosis group | Stays | Average charge | Medicare pays per stay | All hospitals |
|---|---|---|---|---|
| DRG 470 MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC | 91 | $142,037.13 | $21,054.91 | $14,289.25 |
| DRG 219 CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION | 71 | $647,997.90 | $120,466.25 | $69,386.82 |
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $1.48B | $1.65B | -12.0% | -$28.2M | 11,967 | $6.3M | 28.7% | 5.5% |
| 2023 | $1.40B | $1.48B | -5.7% | $42.0M | 11,426 | $4.4M | 29.8% | 5.0% |
| 2022 | $1.11B | $1.34B | -20.9% | -$84.3M | 10,752 | $5.5M | 31.8% | 7.2% |
| 2020 | $1.13B | $1.32B | -16.7% | -$31.2M | 10,433 | $6.6M | 32.3% | 8.1% |
| US median 10.9% |
| Readmission rate after a heart attack | 14.6% | US median 14.4% |
| Readmission rate for heart failure | 20.8% | US median 21.3% |
| Readmission rate after hip or knee replacement | 4.3% | US median 5.8% |
| Readmission rate for pneumonia | 17.2% | US median 17.2% |
| Complications after hip or knee replacement | 4.9% | US median 4.1% |
| Serious complications (patient safety composite) | 0.79 | US median 0.96 · better |
| C. diff intestinal infections (ratio to expected) | 0.64 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.56 | US median 0.48 · better |
| Surgical site infections after colon surgery (ratio to expected) | 0.29 | US median 0.72 · better |
| Surgical site infections after hysterectomy (ratio to expected) | 0.93 | US median 0.81 |
| MRSA bloodstream infections (ratio to expected) | 0.14 | US median 0.60 · better |
| Catheter urinary tract infections (ratio to expected) | 0.15 | US median 0.40 · better |
| Doctors always communicated well | 83% | US median 79% |
| Nurses always communicated well | 80% | US median 80% |
| Patient survey summary star rating | 4 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 58% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 80% | US median 72% |
| Room and bathroom always clean | 72% | US median 73% |
| Patients who would definitely recommend the hospital | 82% | US median 71% |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 18% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 78% | US median 65% |
| Healthcare workers given the flu vaccine | 87% | US median 79% |
| DRG 267 ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITHOUT MCC | 69 | $214,149.87 | $57,231.91 | $40,566.75 |
| DRG 330 MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH CC | 66 | $155,488.98 | $26,600.59 | $18,026.21 |
| DRG 454 COMBINED ANTERIOR AND POSTERIOR SPINAL FUSION WITH CC | 65 | $312,453.40 | $73,361.60 | $49,528.71 |
| DRG 654 MAJOR BLADDER PROCEDURES WITH CC | 64 | $210,580.34 | $29,746.34 | $24,908.76 |
| DRG 274 PERCUTANEOUS AND OTHER INTRACARDIAC PROCEDURES WITHOUT MCC | 61 | $122,054.48 | $37,011.20 | $24,748.54 |
| DRG 657 KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC | 59 | $143,123.61 | $20,145.53 | $15,145.55 |
| DRG 699 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC | 58 | $66,179.05 | $11,299.67 | $8,250.73 |
| DRG 871 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC | 52 | $173,762.35 | $24,727.98 | $15,524.21 |
| DRG 707 MAJOR MALE PELVIC PROCEDURES WITH CC/MCC | 51 | $119,429.61 | $21,717.76 | $16,441.43 |
| DRG 291 HEART FAILURE AND SHOCK WITH MCC | 50 | $103,200.90 | $16,471.98 | $10,022.34 |
| DRG 003 ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PRINCIPAL DIAGNOSIS EXCEPT FACE, MOUTH AND NEC | 48 | $1,777,352.04 | $367,608.48 | $209,579.56 |
| DRG 216 CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITH CARDIAC CATHETERIZATION WIT | 42 | $827,375.40 | $163,007.52 | $90,312.76 |
| DRG 652 KIDNEY TRANSPLANT | 41 | $294,112.34 | $34,738.61 | $26,483.52 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5491 Level 1 Intraocular Procedures | 624 | 436 | $2,269.24 | $1,751.67 |
| APC 5302 Level 2 Upper GI Procedures | 465 | 380 | $1,852.10 | $1,444.50 |
| APC 5153 Level 3 Airway Endoscopy | 357 | 209 | $1,650.23 | $1,264.08 |
| APC 5115 Level 5 Musculoskeletal Procedures | 303 | 285 | $14,322.46 | $10,771.69 |
| APC 5191 Level 1 Endovascular Procedures | 292 | 286 | $2,859.61 | $2,207.96 |
| APC 5492 Level 2 Intraocular Procedures | 241 | 203 | $3,956.03 | $3,116.50 |
| APC 5431 Level 1 Nerve Procedures | 232 | 203 | $1,884.79 | $1,406.61 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 213 | 206 | $1,546.70 | $1,219.56 |
| APC 5114 Level 4 Musculoskeletal Procedures | 202 | 197 | $7,130.47 | $5,338.75 |
| APC 5154 Level 4 Airway Endoscopy | 184 | 148 | $3,651.76 | $2,832.62 |
| APC 5193 Level 3 Endovascular Procedures | 175 | 158 | $11,865.84 | $8,873.86 |
| APC 5373 Level 3 Urology and Related Services | 139 | 124 | $1,993.05 | $1,516.28 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Life Molecular Imaging Ltd | 1 | $482K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 28 | $211K |
| Sanofi US Services Inc. SNY | 26 | $171K |
| Intuitive Surgical, Inc. ISRG | 16 | $121K |
| TG Therapeutics, Inc. TGTX | 1 | $100K |
| Genzyme Corporation SNY | 13 | $65K |
| Hologic Inc HOLX | 1 | $51K |
| W. L. Gore & Associates, Inc. | 6 | $40K |
| Medtronic, Inc. MDT | 15 | $25K |
| Canon Medical Systems USA, Inc. | 3 | $5,600 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Keck Hospital of Usc is a nonprofit short-term acute care hospital in Los Angeles, CA with 307 beds, part of University of Southern California and a 5-star overall rating.
Keck Hospital of Usc in Los Angeles, CA has 307 beds (fiscal year 2025 cost report); 261 beds are certified for Medicare. It discharged 12,230 inpatients that year, with 75.9% of its beds in use on average.
In fiscal year 2025 (ending 2025-09-30), Keck Hospital of Usc reported net patient revenue of $1.48B and operating expenses of $1.78B, a margin on patient care of -20.4%. After other income and expenses its net income was -$121.2M (-7.3% of revenue), so it lost money that year.
Keck Hospital of Usc is part of University of Southern California, a health system with 4 hospitals based in Los Angeles, CA. It is a nonprofit hospital.
Keck Hospital of Usc has an overall rating of 5 out of 5 stars in the official hospital quality ratings. Patients rate it 4 out of 5 stars in the patient survey.
No, Keck Hospital of Usc does not list emergency services.
1,110 Medicare clinicians list Keck Hospital of Usc as a hospital they work at, most often in Nurse Practitioner, Anesthesiology, Physician Assistant.
In 2024, Keck Hospital of Usc had 2,790 Medicare inpatient stays in 110 diagnosis groups. The most common was DRG 470 (major hip and knee joint replacement or reattachment of lower extremity without mcc) with 91 stays; Medicare paid $21,054.91 per stay on average, compared with $14,289.25 across all hospitals.
In 2025, companies reported $1.3M in payments to Keck Hospital of Usc as a teaching hospital ($324K general and $971K for research) from 20 companies.